Your session is about to expire
← Back to Search
Cognitive Training Video Game for Depression
Study Summary
This trial will show how cognitive control training can help reduce depressive symptoms in young people with early warning signs of depression. This could lead to better prevention of depression.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with depression, psychosis, or autism.I am willing to use technology for treatment (technology will be provided if needed).I cannot play video games for any reason.I feel depressed.I have kept my medication doses the same for the last 4 weeks.
- Group 1: Computerized cognitive training (CCT) using EndeavorRx
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research accommodate elderly individuals?
"According to the eligibility criteria, this trial only accepts participants between 9 and 17 years old."
Is this research currently in the process of gathering participants?
"Unfortunately, the clinical trial is no longer taking on new patients. The original posting date was January 1st 2023 and the last update to it occurred on January 21st of that same year. However, there are currently 1133 other trials actively recruiting participants at this moment in time."
Is participation in this clinical trial available to me?
"This clinical trial seeks 30 participants aged between 9 and 17 who suffer from depression. In order to be considered, they must agree to engage with a provided technological intervention, confirm their depressive symptoms, and remain on a stable dose of medication for 4 weeks prior to the initial assessment."
Share this study with friends
Copy Link
Messenger